Literature DB >> 19278658

Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.

Nadine Keller1, Jirí Mares, Oliver Zerbe, Markus G Grütter.   

Abstract

Caspases are proteases with an active-site cysteine and aspartate specificity in their substrates. They are involved in apoptotic cell death and inflammation, and dysfunction of these enzymes is directly linked to a variety of diseases. Caspase-8 initiates an apoptotic pathway triggered by external stimuli. It was previously characterized in its active inhibitor bound state by crystallography. Here we present the solution structure of the monomeric unprocessed catalytic domain of the caspase-8 zymogen, procaspase-8, showing for the first time the position of the linker and flexibility of the active site forming loops. Biophysical studies of carefully designed mutants allowed disentangling dimerization and processing, and we could demonstrate lack of activity of monomeric uncleaved procaspase-8 and of a processed but dimerization-incompetent mutant. The data provide experimental support in so-far unprecedented detail, and reveal why caspase-8 (and most likely other initiator caspases) needs the dimerization platform during activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278658     DOI: 10.1016/j.str.2008.12.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  38 in total

1.  BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane.

Authors:  Z T Schug; F Gonzalvez; R H Houtkooper; F M Vaz; E Gottlieb
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

2.  Src-inducible association of CrkL with procaspase-8 promotes cell migration.

Authors:  Ryon Graf; Simone Barbero; Nadine Keller; Lauren Chen; Sean Uryu; David Schlaepfer; Dwayne Stupack
Journal:  Cell Adh Migr       Date:  2013-06-10       Impact factor: 3.405

3.  In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moiety.

Authors:  Rajkumar Ganesan; Stjepan Jelakovic; Peer R E Mittl; Amedeo Caflisch; Markus G Grütter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-07-13

4.  Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8.

Authors:  Veronika Kanderova; Hana Grombirikova; Irena Zentsova; Kamila Reblova; Adam Klocperk; Martina Fejtkova; Marketa Bloomfield; Barbora Ravcukova; Tomas Kalina; Tomas Freiberger; Anna Sediva
Journal:  Haematologica       Date:  2018-10-18       Impact factor: 9.941

5.  Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion.

Authors:  S Leverrier; G S Salvesen; C M Walsh
Journal:  Cell Death Differ       Date:  2010-06-04       Impact factor: 15.828

Review 6.  Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate.

Authors:  Bram J van Raam; Guy S Salvesen
Journal:  Biochim Biophys Acta       Date:  2011-06-16

Review 7.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

8.  Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis.

Authors:  Bart Tummers; Luigi Mari; Clifford S Guy; Bradlee L Heckmann; Diego A Rodriguez; Sebastian Rühl; Julien Moretti; Jeremy Chase Crawford; Patrick Fitzgerald; Thirumala-Devi Kanneganti; Laura J Janke; Stephane Pelletier; J Magarian Blander; Douglas R Green
Journal:  Immunity       Date:  2020-05-18       Impact factor: 31.745

Review 9.  Caspase-8 as a regulator of tumor cell motility.

Authors:  R P Graf; N Keller; S Barbero; D Stupack
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

10.  Protease activity of procaspase-8 is essential for cell survival by inhibiting both apoptotic and nonapoptotic cell death dependent on receptor-interacting protein kinase 1 (RIP1) and RIP3.

Authors:  Mina Kikuchi; Shunsuke Kuroki; Mitsuhiro Kayama; Shota Sakaguchi; Kyung-Kwon Lee; Shin Yonehara
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.